TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Vaccinium Invest AB
Closing information (x1000 SEK)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
25,084
|
45,339
|
0 |
| Financial expenses |
0
|
1
|
158 |
| Earnings before taxes |
14,424
|
5,429
|
-127 |
| EBITDA |
3,912
|
-620
|
-20 |
| Total assets |
14,283
|
9,935
|
3,957 |
| Current assets |
14,133
|
9,785
|
3,807 |
| Current liabilities |
903
|
0
|
1 |
| Equity capital |
13,380
|
9,935
|
3,956 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
93.7%
|
100%
|
100.0% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
57.5%
|
12.0% | |
| Return on assets (ROA) |
101.0%
|
54.7%
|
0.8% |
| Current ratio | 1565.1% | 380700% | |
| Return on equity (ROE) |
107.8%
|
54.6%
|
-3.2% |
| Change turnover |
-20,255
|
45,339
|
0 |
| Change turnover % | -45% | ||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.